Show simple item record

dc.contributor.authorBuckler, Brad
dc.contributor.authorBell, Jason
dc.contributor.authorSams, Ralph
dc.contributor.authorCagle, William
dc.contributor.authorBell, Sue Anne
dc.contributor.authorAllen, Carla
dc.contributor.authorSutherland, Donald E.
dc.contributor.authorBhatia, Jatinder
dc.date.accessioned2012-10-26T16:26:49Z
dc.date.available2012-10-26T16:26:49Z
dc.date.issued2010-08-22en_US
dc.identifier.citationInfect Dis Obstet Gynecol. 2010 Aug 22; 2010:369654en_US
dc.identifier.issn1098-0997en_US
dc.identifier.pmid20827303en_US
dc.identifier.doi10.1155/2010/369654en_US
dc.identifier.urihttp://hdl.handle.net/10675.2/592
dc.description.abstractAsymptomatic term neonates born to mothers who are Group B Streptococcus (GBS) unknown or GBS positive but â inadequatelyâ treated prior to delivery do not require invasive laboratory evaluation. We conducted a retrospective cohort study of mother/baby dyads born from January 1, 2005 until September 30, 2007 at the Medical College of Georgia. Their current protocol is to obtain a Complete Blood Count with Differential (CBC with D), Blood Culture (BC), and C-reactive protein (CRP) after birth. Mother/baby dyads (n = 242) that met inclusion criteria were reviewed. Of these 242 babies 25 (10%) were started on antibiotics after the initial lab values were known. None of the blood cultures were positive and the CRP's were normal. The 2002 GBS guidelines call for laboratory evaluation of â at-riskâ neonates, but the workup of these babies is not only costly, it does not provide any advantage over old fashioned clinical observation for the evaluation and treatment of early onset GBS sepsis.
dc.rightsCopyright © 2010 Brad Buckler et al.en_US
dc.subjectResearch Articleen_US
dc.subject.meshAnti-Bacterial Agentsen_US
dc.subject.meshBacteremiaen_US
dc.subject.meshBlood Cell Counten_US
dc.subject.meshC-Reactive Proteinen_US
dc.subject.meshCohort Studiesen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshInfant, Newbornen_US
dc.subject.meshPregnancyen_US
dc.subject.meshPregnancy Complications, Infectiousen_US
dc.subject.meshRetrospective Studiesen_US
dc.subject.meshSepsisen_US
dc.subject.meshStreptococcal Infectionsen_US
dc.subject.meshStreptococcus agalactiaeen_US
dc.titleUnnecessary Workup of Asymptomatic Neonates in the Era of Group B Streptococcus Prophylaxisen_US
dc.typeArticleen_US
dc.identifier.pmcidPMC2933854en_US
dc.contributor.corporatenameDepartment of Pediatrics
dc.contributor.corporatenameDepartment of Pediatrics
dc.contributor.corporatenameDepartment of Obstetrics and Gynecology
dc.contributor.corporatenameGeorgia Institute for Prevention of Human Diseases and Accidents
refterms.dateFOA2019-04-09T22:04:57Z
html.description.abstractAsymptomatic term neonates born to mothers who are Group B Streptococcus (GBS) unknown or GBS positive but â inadequatelyâ treated prior to delivery do not require invasive laboratory evaluation. We conducted a retrospective cohort study of mother/baby dyads born from January 1, 2005 until September 30, 2007 at the Medical College of Georgia. Their current protocol is to obtain a Complete Blood Count with Differential (CBC with D), Blood Culture (BC), and C-reactive protein (CRP) after birth. Mother/baby dyads (n = 242) that met inclusion criteria were reviewed. Of these 242 babies 25 (10%) were started on antibiotics after the initial lab values were known. None of the blood cultures were positive and the CRP's were normal. The 2002 GBS guidelines call for laboratory evaluation of â at-riskâ neonates, but the workup of these babies is not only costly, it does not provide any advantage over old fashioned clinical observation for the evaluation and treatment of early onset GBS sepsis.


Files in this item

Thumbnail
Name:
IDOG2010-369654.pdf
Size:
451.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record